Skinmy is a health-tracking app for iOS that provides AI-powered mole scanning, body mapping, and skincare ingredient analysis.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual skin monitoring by automating ABCDE analysis and providing a centralized repository for historical mole changes.
For Individuals concerned with skin health, mole monitoring, and ingredient-conscious skincare routines.
What does it look like?
Key features
On-device ABCDE analysis for risk assessment.
16-zone mapping with historical comparison.
Ingredient safety scoring and alternative suggestions.
How much does it cost?
Hybrid model combining recurring revenue for tracking features with transactional fees for professional medical review services.
Velocity
Dormant developmentperformanceShow more...
Skinmy: Skin Health Tracker has entered a state of inactivity, with no new feature builds or updates released in the last 128 days. The development cadence is currently non-existent, falling well below the threshold for maintenance. The most recent release was limited to minor bug fixes and typo corrections, indicating a lack of active feature development or ongoing support.
Who built it?
Mimi Studio
2 apps tracked · Health & Fitness
Yummy Starts: Baby First FoodsUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Skinmy: Skin Health Tracker
How's the Health & Fitness market?
Skinmy operates in the Health & Fitness category with a 4.6-star rating across 22 reviews. The lack of recent updates (128 days since the last release) limits its ability to compete for chart visibility against more active health-tracking utilities.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Skinmy: Skin Health Tracker
Where is it heading?
The health-tracking market is consolidating around apps with high-frequency update cadences that provide daily utility. Skinmy's current maintenance-only posture leaves it exposed to more agile competitors who can iterate on AI diagnostic accuracy and routine-building features.
- The 128-day release gap signals a lack of active development, which increases churn risk for subscription-based health apps.
- The hybrid monetization model remains unproven in the absence of consistent feature updates to drive daily active usage.
The SWOT
- On-device AI processing ensures user privacy for sensitive imagery
- 16-zone body mapping provides structured longitudinal monitoring
- Affiliate integration with pharmacy inventory for safer product alternatives
Next best moves
Ship a stability-focused update because the 128-day release gap signals abandonment to users → improve retention
The counter-intuitive read
The 128-day release gap is not just a maintenance failure…
Read the full takeSince the last report: The outlook for the app has moved from mixed to declining, as the 128-day release gap is now framed as a fundamental strategic risk to user trust and competitive standing.
Bottom line
Skinmy provides a functional tool for longitudinal skin monitoring, but the 4-month release gap suggests a lack of active feature investment. The PM should prioritize stability and core-loop retention to justify the $14.99/month price point against emerging health competitors.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
Report last updated